NetworkNewsBreaks – Earth Science Tech Inc. (ETS
Post# of 333
(Total Views: 606)
Posted On: 08/20/2019 6:34:55 PM
NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Establishing Role as Global CBD Industry Leader
Earth Science Tech (OTCQB: ETST), together with its wholly owned subsidiaries, is working to advance its role as a leader in the global CBD sector. An article discussing the company reads, “Another subsidiary of Earth Science Tech is Cannabis Therapeutics Inc. Cannabis Therapeutics is committed to become a global leader in cannabinoid research and development (R&D) for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions. Its mission is to help change the health care landscape by introducing proprietary products made for the global pharmaceutical- and retail-consumer markets. . . . Cannabis Therapeutics has a provisional application patent for CBD and is invested in R&D to explore and harness the medicinal power of cannabidiol. The company is working to develop CBD-based drugs and nutraceutical products and is also working to integrate CBD molecules with existing generic drug molecules. Cannabis Therapeutics is concentrating on developing pioneering products that provide treatment options for patients and physicians.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Earth Science Tech (OTCQB: ETST), together with its wholly owned subsidiaries, is working to advance its role as a leader in the global CBD sector. An article discussing the company reads, “Another subsidiary of Earth Science Tech is Cannabis Therapeutics Inc. Cannabis Therapeutics is committed to become a global leader in cannabinoid research and development (R&D) for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions. Its mission is to help change the health care landscape by introducing proprietary products made for the global pharmaceutical- and retail-consumer markets. . . . Cannabis Therapeutics has a provisional application patent for CBD and is invested in R&D to explore and harness the medicinal power of cannabidiol. The company is working to develop CBD-based drugs and nutraceutical products and is also working to integrate CBD molecules with existing generic drug molecules. Cannabis Therapeutics is concentrating on developing pioneering products that provide treatment options for patients and physicians.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Earth Science Tech, Inc. (ETST) Stock Research Links
Scroll down for more posts ▼